A therapeutic agent injection device including an injection device for delivering a therapeutic agent to a patient having a body, the body having a patient face and a port face opposite the patient face, the port face having an introducer port including an introducer channel and an injection port including an injection channel, the introducer channel being in fluid communication with the injection channel through a cross channel, the injection channel defining an injection axis; a delivery tube for subcutaneous delivery of the therapeutic agent to the patient, the delivery tube projecting from and being generally perpendicular to the patient face, the delivery tube defining an introducer axis and being in fluid communication with the injection port; and a patch, the patch being attached to the patient face and being operable to adhesively attach to the patient; wherein the injection axis is parallel to the introducer axis.

Systems, devices, and methods for delivering therapeutic particles are disclosed. In one variation, a device for delivering particles includes a gas supply configured for supplying gas under pressure, a particle cassette comprising the particles, a cassette housing, and a cassette membrane. The cassette housing can comprise an Ethylene Vinyl Acetate (EVA) copolymer of 18% to 28% by weight of Vinyl Acetate (VA). The device can also include a safety interlock to prevent or minimize the risk that the device will be unintentionally activated. The device can also have a silencer.

An apparatus for injectate delivery includes a cartridge, a linear actuator, a rotary motor mechanically coupled the actuator, and a controller coupled to the motor. The controller controls a linear motion of the actuator by controlling an electrical input supplied to the motor in a first interval during which the motor is stationary with the linear actuator engaged with the cartridge to displace an injectate in the cartridge, a second interval following the first interval during which the controller accelerates the motor from stationary to a first speed selected to create a jet of the injectate from the cartridge with a velocity sufficient to pierce human tissue to a subcutaneous depth, a third interval during which the controller maintains the motor at or above the first speed, and a fourth interval during which the controller decelerates the motor to a second speed to deliver the injectate at the subcutaneous depth.

A method for filling a cylinder/piston unit (1) for a needle-free injector comprising a chamber (3) arranged in a cylinder (2), for receiving an injection solution (4), a front wall (5) having at least one nozzle borehole or an outlet element (6), and a second piston (7) arranged to move in the chamber. The chamber (3) is made in two parts with a first chamber (8) and a concentric second chamber (9) having a smaller cross section than the first chamber. A first piston (10) closes the first chamber (8) and the second piston closes the second chamber (9). The second piston comprises at least one flow channel (16) or the first chamber comprises at least one closable, axially oriented freeze-drying channel (34), and the second chamber (9) comprises at least one axially oriented flow channel (36), on the respective rear ends of the chambers (8, 9).

The described technology relates to a needleless syringe for injecting an injection objective substance into an injection target area. The needleless syringe includes a protruding member which is provided movably from a first position to a second position at which 1) a protruding length of a forward end of the protruding member from an end surface of a housing is shorter than a protruding length of the forward end at the first position and 2) the forward end and a discharge port can be brought in contact with the injection target area. The needleless syringe also includes a maintaining mechanism which maintains the protruding member at the first position and a power source circuit which applies a voltage to a driving unit when the protruding member having been maintained at the first position is moved to the second position. Accordingly, the unintended discharge from the syringe is appropriately avoided.

A therapeutic agent injection device including an injection device for delivering a therapeutic agent to a patient having a body, the body having a patient face and a port face opposite the patient face, the port face having an introducer port including an introducer channel and an injection port including an injection channel, the introducer channel being in fluid communication with the injection channel through a cross channel, the injection channel defining an injection axis; a delivery tube for subcutaneous delivery of the therapeutic agent to the patient, the delivery tube projecting from and being generally perpendicular to the patient face, the delivery tube defining an introducer axis and being in fluid communication with the injection port; and a patch, the patch being attached to the patient face and being operable to adhesively attach to the patient; wherein the injection axis is parallel to the introducer axis.

The present Invention relates to a kit for applying a liquid composition on or in the skin, comprising an injection device and one or more cartridges, provided with a container appropriate for receiving a liquid composition, in which the injection device is provided with means for receiving a cartridges, characterized in that the container is provided with a movable body. The cartridge is provided with a peripheral edge, that allows the safe removal of a used cartridge out of the device, In a second aspect, the invention relates to a method for applying a liquid composition onto the skin.

The present disclosure relates to a needleless injector including a cap, an injection system, a body, a gas generator, and a percussion device. The body is covered by the cap and is mounted to slide relative to the cap. The percussion device includes a striker that is slidingly mounted along a sliding axis between a rest position and a percussion position and a lock mechanism. The lock mechanism includes a lug and a retention tab. The lug projects from a peripheral face of the striker along an axis that is perpendicular to the sliding axis and has a first support ramp. The retention tab is attached to the cap, and has a second support ramp. The ramps are configured to move the retention tab radially when pushed by the striker from a retaining position to a release position and the retention tab is moved aside to release the striker.

The present disclosure is directed towards a needleless injection device that includes a body, a gas generator, an injection system that extends axially along an injection axis and includes at least one plunger, an active ingredient reservoir, an injection nozzle that delimits at least one injection channel, a cover that houses the body of the device, a removable cap that protects a lower downstream end of the injection nozzle, a stopper that houses the cap, and a blocking element. The stopper is pivotally mounted about the injection axis between a closed position in which the stopper is locked on the injection device and an open position in which the stopper is unlocked from the injection device. The blocking element is radially interposed between the cap and the stopper, and is configured to block, by friction, the relative pivoting of the cap and of the stopper, about the injection axis.

The present disclosure relates to a needleless injector including a cap, an injection system, a body, and a compression spring. The body is mounted to slide upwards in relation to the cap along an injection axis between a rest position and an injection position. The compression spring is axially intercalated along the injection axis between the body and the cap to compress the skin tissue of the user when the nozzle is applied to the skin. The compression spring is a frustroconical helical spring that extends along the injection axis and includes a plurality of turns designed to nest axially one inside the other.